M.a. Med Alliance S.a.
Clinical trials sponsored by M.a. Med Alliance S.a., explained in plain language.
-
New balloon treatment could help millions with clogged leg arteries
Disease control OngoingThis study is testing a special balloon coated with a drug that slowly releases medication to keep leg arteries open in people with peripheral artery disease. About 723 participants will receive the balloon treatment and be followed for one year to see if it reduces the need for …
Phase: NA • Sponsor: M.A. Med Alliance S.A. • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
New balloon could keep leg arteries open longer for PAD patients
Disease control OngoingThis study tests a special balloon coated with a drug (SELUTION SLR™ 018) to treat blocked arteries in the leg caused by peripheral artery disease (PAD). About 300 people will be randomly assigned to receive either the drug-coated balloon or a standard uncoated balloon. The goal …
Phase: NA • Sponsor: M.A. Med Alliance S.A. • Aim: Disease control
Last updated May 26, 2026 04:35 UTC
-
Balloon vs. stent: new hope for clogged heart arteries?
Disease control OngoingThis study tests a special balloon coated with a drug to treat heart arteries that have narrowed again after a previous stent placement. About 418 adults with this condition will be randomly assigned to receive either the drug-coated balloon or standard care (another stent or pla…
Phase: NA • Sponsor: M.A. Med Alliance S.A. • Aim: Disease control
Last updated May 26, 2026 04:31 UTC
-
Heart artery showdown: balloon vs stent in 3,300 patients
Disease control OngoingThis study compares two ways to treat coronary artery disease: a drug-coated balloon (Selution DEB) and a drug-eluting stent (DES). About 3,300 adults with blocked heart arteries will be randomly assigned to one of the two treatments. The goal is to see which approach better prev…
Phase: NA • Sponsor: M.A. Med Alliance S.A. • Aim: Disease control
Last updated May 22, 2026 13:52 UTC